EDGEWISE THERAPEUTICS INC (EWTX) Stock Earnings & Estimates
NASDAQ:EWTX - US28036F1057 - Common Stock
14.35 USD
-0.3 (-2.05%)
14.35 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 1,335.42% | N/A 417.42% | N/A 165.82% | N/A 85.88% | N/A 56.70% | N/A 54.01% | |||||||
| EBITDA YoY % growth | -9.8M | -17M -73.47% | -42.95M -152.65% | -71.29M -65.98% | -112.625M -57.98% | -156.542M -38.99% | N/A -25.98% | N/A -20.54% | N/A -16.62% | N/A 53.27% | N/A 347.73% | N/A 108.12% | N/A 50.02% | N/A 62.87% | |
| EBIT YoY % growth | -9.92M | -17.19M -73.29% | -43.22M -151.43% | -71.66M -65.80% | -114.357M -59.58% | -158.832M -38.89% | N/A -20.08% | N/A -24.53% | N/A -9.19% | N/A 32.99% | N/A 129.06% | N/A 509.65% | N/A 87.02% | N/A 82.34% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -0.87 | -1.27 -45.98% | -1.58 -24.41% | -1.45 8.23% | N/A -13.55% | N/A -21.80% | N/A -5.19% | N/A 33.27% | N/A 135.92% | N/A 380.41% | N/A 75.25% | N/A 71.97% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.41 -12.86% | -0.45 -6.86% | -0.47 -8.78% | -0.48 -40.57% | -0.52 -28.03% | -0.54 -20.45% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | -48.671M -25.54% | -52.3M -20.92% | -58.543M -28.93% | -61.571M -48.40% | -64.6M -32.73% | -67.625M -29.30% |
| EBIT Q2Q % growth | -48.294M -19.45% | -52.248M -14.73% | -54.072M -17.65% | -55.367M -29.94% | -60.307M -24.87% | -63.911M -22.32% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.34 | -0.42 | 0.08 | 19.77% |
| Q1 2025 Q2Q % growth | -0.43 -30.30% | -0.44 | 0.01 | 1.73% |
| Q4 2024 Q2Q % growth | -0.42 10.64% | -0.43 | 0.01 | 1.18% |
| Q3 2024 Q2Q % growth | -0.36 12.20% | -0.38 | 0.02 | 4.98% |
| Q2 2024 Q2Q % growth | -0.34 | -0.35 | 0.01 | 3.18% |
| Q1 2024 Q2Q % growth | -0.33 8.33% | -0.40 | 0.07 | 17.47% |
| Q4 2023 Q2Q % growth | -0.47 -51.61% | -0.44 | -0.03 | -6.17% |
| Q3 2023 Q2Q % growth | -0.41 -20.59% | -0.40 | -0.01 | -1.51% |
| Q2 2023 Q2Q % growth | -0.34 -6.25% | -0.41 | 0.07 | 16.25% |
| Q1 2023 Q2Q % growth | -0.36 -20.00% | -0.37 | 0.01 | 1.96% |
| Q4 2022 Q2Q % growth | -0.31 -19.23% | -0.34 | 0.03 | 9.55% |
| Q3 2022 Q2Q % growth | -0.34 -30.77% | -0.36 | 0.02 | 6.37% |
| Q2 2022 Q2Q % growth | -0.32 -52.38% | -0.33 | 0.01 | 3.17% |
| Q1 2022 Q2Q % growth | -0.30 -114.29% | -0.28 | -0.02 | -5.80% |
| Q4 2021 Q2Q % growth | -0.26 | -0.25 | -0.01 | -2.99% |
| Q3 2021 Q2Q % growth | -0.26 | -0.23 | -0.03 | -14.14% |
| Q2 2021 Q2Q % growth | -0.21 | -0.18 | -0.03 | -15.99% |
| Q1 2021 Q2Q % growth | -0.14 | -0.16 | 0.02 | 12.85% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 9.09% | 13.14% | 8.08% | 8.7% |
| Revenue | N/A | N/A | N/A | N/A |